Both formulations share the same overall profile because the molecule is the same: semaglutide
It has become one of the most rapidly growing global epidemics over the past three decades, with a prevalence of 27.5% in adults and 47.1% in children.[9] Although sarcopenia and obesity share both overlapping and distinct characteristics, a growing concern is the emergence of sarcopenic obesity, a condition that requires a different therapeutic approach from either disease alone
Hydration with coffee, soda, juices, and other sweet beverages will increase your chance of dehydration
Body Forward currently provides services to all US States What if I need to cancel
Semaglutide May Be Ideal If You: Prefer a more established, widely available option Are beginning your medical weight loss journey Want to test GLP-1 therapy before considering dual-action drugs Have moderate weight-related health concerns Tirzepatide May Be Ideal If You: Are struggling with more resistant weight Want the most advanced option available for fat reduction Have pre-diabetes, insulin resistance, or other metabolic concerns Did not see optimal results with GLP-1 therapy alone Safety and Side Effects Both medications are well-tolerated by most patients, though they can cause side effects such as: Nausea Fatigue Constipation or Diarrhea Mild injection site irritation The risk and intensity of side effects tend to be dose-dependent and usually subside as your body adjusts
